Exxat key facts
as of Oct 2026- Developer of an education management platform designed to improve clinical educational outcomes.
- Exxat is valued at approximately $217.0M as of Oct 2026 (last reported valuation).
- It has raised $45.0M; the latest was PE Growth/Expansion ($45.0M) in Jan 2026.
- Notable investors include Accel-KKR.
- Status: Privately Held (backing).
Exxat's last reported valuation, Jan 2026. Nothing priced has surfaced since.
- ·Watch Exxat: the Monday email on marks, rounds and moves
Exxat funding rounds
No funding rounds for Exxat are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Exxat
1Exxat valuation
Exxat's last reported valuation was $217 million in Jan 2026. No priced round, secondary trade or fund mark has surfaced since.
Exxat investors
1 investor is on record for Exxat, including Accel-KKR. By type, the record holds 1 private equity firm.
About Exxat
Developer of an education management platform designed to improve clinical educational outcomes. The company offers solutions for curriculum management, competency tracking, accreditation support, placement coordination, site collaboration, compliance tracking, workflow streamlining, and contract sharing, thereby helping institutions administer and scale allied health and clinical education programs in a unified manner.
- Sector
- Information Technology
- HQ
- Warren, NJ, United States
- Founded
- 2011
- Employees
- 434
- Website
- exxat.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.